Iovance Biotherapeutics (IOVA) Cost of Revenue (2023 - 2026)
Iovance Biotherapeutics (IOVA) recorded Cost of Revenue of $43.6 million in Q2 2026, down 10.8% from $48.88 million a year earlier but up 2.6% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Cost of Revenue (2023 - 2026) Analysis & Trends
On a TTM basis, Iovance Biotherapeutics' Cost of Revenue came in at $167.68 million as of Jun 30, 2026, up 4.2% year-over-year; for FY2025, it came in at $173.18 million, up 85.7% from FY2024.
- Across earlier years, Cost of Revenue came in at $93.25 million in FY2024 and $1.03 million in FY2023.
- Quarterly Cost of Revenue has ranged from -$5.36 million in Q4 2023 to $48.88 million in Q2 2025 over the past five years.
- On a year-over-year basis, Cost of Revenue rose in five of the last seven quarters, with growth averaging 170.7%.
- Per Business Quant, the preceding three quarters came in at $42.5 million (Q1 2026), $43.11 million (Q4 2025) and $38.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Iovance Biotherapeutics | 6.38 Bn | 5.17 Bn | 55.72 Mn | 43.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.60 Mn |
| Mar 31, 2026 | 42.50 Mn |
| Dec 31, 2025 | 43.11 Mn |
| Sep 30, 2025 | 38.48 Mn |
| Jun 30, 2025 | 48.88 Mn |
| Mar 31, 2025 | 42.72 Mn |
| Dec 31, 2024 | 37.79 Mn |
| Sep 30, 2024 | 31.52 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | -5.36 Mn |
| Sep 30, 2023 | 4.34 Mn |
| Jun 30, 2023 | 2.05 Mn |
API Access
Iovance Biotherapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();